Contrast-induced nephropathy;Kontrastmittel-induzierte nephropathie

Intensivmedizin und Notfallmedizin

Volumn 42, Issue 1, 2005, Pages 39-46

  Erley, C M ^a  

^a ST JOSEPH KRANKENHAUS   (Germany)

Author keywords

Acetylcysteine; Adenosine antagonists; Bicarbonate; Contrast induced nephropathy; Hydration

Indexed keywords

ACETYLCYSTEINE; ATRIAL NATRIURETIC FACTOR; CALCIUM ANTAGONIST; CONTRAST MEDIUM; DOPAMINE; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; CALCIUM ANTAGONISM; DIALYSIS; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; HYDRATION; MORTALITY; NONHUMAN; REVIEW;

EID: 15044355747     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-005-0563-3     Document Type: Review

References (77)

1. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9(8):1602-1613
2. Bettmann MA (1991) The evaluation of contrast-related renal failure [comment]. AJR Am J Roentgenol 157:66-68
3. Hunter JV, Kind PRN (1992) Nonionic iodinated contrast media: potential renal damage assessed with enzymuria. Radiology 183:101-104
4. Byrd L, Sherman RL (1979) Radiocontrast-induced acute renal failure: a clinical and pathological review. Medicine 58:270-279
5. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J et al (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143-149
6. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN et al (1989) Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320: 149-153
7. Berns AS (1989) Nephrotoxicity of contrast media [clinical conference]. Kidney Int 36(4):730-740
8. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ et al (1989) Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110:119-124
9. VanZee BE, Hoy WE, Talley TE, Jaenike JR (1978) Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 89(1):51-54
10. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S et al (1992) Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 182(3):649-655
11. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D et al (1992) Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 41:1274-1279
12. Miller DL, Chang R, Wells WT, Dowjat BA, Malinosky RM, Doppman JL (1988) Intravascular contrast media: effect of dose on renal function. Radiology 167(3):607-611
13. Rosovsky MA, Rusinek H, Berenstein A, Basak S, Setton A, Nelson K (1996) High-dose administration on nonionic contrast media: a retrospective review. Radiology 200:119-122. Ref Type: Journal (Full)
14. Donaldson IML (1968) Comparosin of the renal clearance of inulin and radioactive diatrizoate as measures for glomerular filtration rate in man. Clin Sci 35:513-519
15. Barrett BJ, Parfrey PS, McDonald JR, Hefferton DM, Reddy ER, McManamon PJ (1992) Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial [see comments]. Radiology 183:105-110
16. Deray G, Jacobs C (1995) Radiocontrast nephrotoxicity. A review. Invest Radiol 30(4):221-225
17. Katholi RE, Taylor GJ, Woods WT, Womack KA, Katholi CR, McCann WP et al (1993) Nephrotoxicity of nonionic low-osmolality versus ionic high- osmolality contrast media: a prospective double-blind randomized comparison in human beings. Radiology 186:183-187
18. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254-261
19. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188: 171-178
20. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ et al (2003) Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. N Engl J Med 348(6):491-499
21. Weissleder R (1996) Can gadolinium be safely given in renal failure? AJR Am J Roentgenol 167(1):278-279
22. Kaufman JA, Geller SC, Waltman AC (1996) Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 198(2):579-581
23. 2-enhanced renal angiography for diagnosis and percutaneous treatment. Radiology 210(3):663-672
24. Hammer FD, Goffette PP, Malaise J, Mathurin P (1999) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9(1):128-136
25. Swan SK, Lambrecht LJ, Townsend R, Davies BE, McCloud S, Parker JR et al (1999) Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 34(7):443-448
26. Arsenault TM, King BF, Marsh-JW J, Goodman JA, Weaver AL, Wood CP et al (1996) Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 71(12):1150-1154
27. Tombach B, Bremer C, Reimer P, Kisters K, Schaefer RM, Geens V et al (2001) Renal tolerance of a neutral gadolinium chelate (gadobutrol in patients with chronic renal failure: Results of a randomized study. Radiology 218(3):651-657
28. Erley CM, Bader BD, Berger ED, Tuncel N, Winkler S, Tepe G et al (2004) Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrology Dialysis Transplantation 19(10):2526-2531
29. Sancak T, Bilgic S, Sanlidilek U (2002) Gadodiamide as an alternative contrast agent in intravenous digital subtraction angiography and interventional procedures of the upper extremity veins. Cardiovascular and Interventional Radiology 25(1):49-52
30. Seeger JM, Self S, Harward TR, Flynn TC, Hawkins IF Jr (1993) Carbon dioxide gas as an arterial contrast agent. Ann Surg 217(6):688-697
31. Hawkins IF Jr, Wilcox CS, Kerns SR, Sabatelli FW (1994) CO2 digital angiography: a safer contrast agent for renal vascular imaging? Am J Kidney Dis 24(4):685-694
32. Zwaan M, Kloess W, Kagel C, Kummer KD, Matthies ZS, Schutz RM et al (1996) [Carbon dioxide as an alternative contrast medium in peripheral angiography (published erratum appears in Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr Aug; 165(2):180)]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 164(5):445-448
33. 2) (carbo-angiography) in patients with increased contrast media risk]. Zentralbl Chir 122(9):725-729
34. Solomon R, Werner C, Mann D, D'Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420
35. Carraro M, Stacul F, Collari P, Toson D, Zucconi F, Torre R et al (1993) Contrast media nephrotoxicity: urinary protein and enzyme pattern in patients with or without saline infusion during digital subtracting angiography. Contrib Nephrol 101:251-254
36. Jakobsen JA (1995) Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol Suppl 399:191-195
37. Shieh SD, Hirsch SR, Boshell BR, Pino JA, Alexander LJ, Witten DM et al (1982) Low risk of contrast mediainduced acute renal failure in nonazotemic type 2 diabetes mellitus. Kidney Int 21(5):739-743
38. Taylor AJ, Hotchkiss D, Morse RW, McCabe J (1998) PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114(6):1570-1574
39. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T et al (2004) What is the best hydration regimen to prevent contrast mediainduced nephrotoxicity? Clinical Nephrology 62(1):1-7. Ref Type: Journal (Full)
40. Heyman SN, Brezis M, Greenfeld Z, Rosen S (1989) Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 14(5):377-385
41. Golman K, Cederholrn C (1990) Contrast medium-induced acute renal failure. Can it be prevented? Invest Radiol 25 Suppl 1:S127-S128
42. Weinstein JM, Heyman S, Brezis M (1992) Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413-415
43. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162(3):329-336
44. Erley CM, Heyne N, Burgert K, Langanke J, Risler T, Osswald H (1997) Prevention of radiocontrast induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. J Am Soc Nephrol 8(7): 1125-1132
45. Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Müller C et al (1999) Prevention of RadiocontrastMedia-Induced Nephropathy in Patients with Preexisting Renal Insufficiency by Hydration in Combination with the Adenosine Antagonist Theophylline. Nephrol Dial Transplant 14(5):1146-1149
46. Erley CM, Duda SH, Schlepckow S, Koehler J, Huppert PE, Strohmaier WL et al (1994) Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 45:1425-1431
47. Katholi RE, Taylor GJ, McCann WP, Woods WT, Womack KA, McCoy CD et al (1995) Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 195:17-22
48. Wagner HJ, Kalinowski M, Klose KJ, Alfke H (2001) The use of gadolinium chelates for x-ray digital subtraction angiography. Investigative Radiology 36(5):257-265
49. Kapoor A, Kumar S, Gulati S, Gambhir S, Sethi RS, Sinha N (2002) The role of theophylline in contrast-induced nephropathy: a case-control study. Nephrology Dialysis Transplantation 17(11):1936-1941
50. Wambach G, Winkert T (1990) Nierenfunktionsstörungen nach Röntgenkontrastmittelgabe: Prophylaxe durch das atriale natriuretische Peptid? Nieren- und Hochdruckkrankheiten 19:312-317
51. Margulies KB, McKinley LJ, Cavero PG, Burnett JCJ (1990) Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. Kidney Int 38:1101-1108
52. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW et al (1994) Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45(6):1731-1738
53. Fenves AZ, Allgren RL (1995) Radiocontrast dye-induced acute tubular necrosis (ATN): atrial natriuretic peptide (ANP) versus placebo. J Am Soc Nephrol 6:463. Ref Type: Abstract
54. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31(4):674-680
55. Bakris GL, Burnett JCJ (1985) A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int 27:465-468
56. Neumayer HH, Junge W, Kufner A, Wenning A (1989) Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transplant 4:1030-1036
57. Russo D, Testa A, Volpe LD, Sansone G (1990) Randomised propspective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 55:254-257
58. Carraro M, Mancini W, Artero M, Stacul F, Grotto M, Cova M et al (1996) Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transplant 11(3):444-448
59. Spangberg Viklund B, Berglund J, Nikonoff T, Nyberg P, Skau T, Larsson R (1996) Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function? Scand J Urol Nephrol 30(1):63-68
60. Weisberg LS, Kurnik PB, Kurnik BR (1993) Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 15: 61-68
61. Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH et al (1992) Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 53(4):317-320
62. Kapoor A, Sinha N, Sharma RK, Shrivastava S, Radhakrishnan S, Goel PK et al (1996) Use of dopamine in prevention of contrast induced acute renal failure - a randomised study. Int J Cardiol 53(3):233-236
63. Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD et al (1999) Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 83(2): 260-263, A5
64. Chertow GM, Lazarus JM, Sayegh MH, Allgren RL (1995) Is the administration of dopamine associated with adverse outcomes in severe acute renal failure? J Am Soc Nephrol 6:460 Ref Type: Abstract
65. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R (1997) TI - N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 272:F292-F298
66. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine. N Engl J Med 343(3):180-184
67. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C (2003) Acetylcysteine for prevention of contrast nephropathy: metaanalysis. Lancet 362(9384):598-603
68. Pannu N, Manns B, Lee H, Tonelli M (2004) Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney International 65(4):1366-1374
69. Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G et al (2004) N-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy: A Meta-Analysis of Prospective Controlled Trials. Journal Of The American Society Of Nephrology 15(3):761-769
70. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK (2004) The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable. Journal Of The American Society Of Nephrology 15(2):407-410
71. Fishbane S, Durham JH, Marzo K, Rudnick M (2004) N-Acetylcysteine In The Prevention Of Radiocontrast-Induced Nephropathy. Journal Of The American Society Of Nephrology 15(2):251-260
72. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291(19):2328-2334
73. Lehnert T, Gondolf K, Schäffner T, Schollmeyer P, Keller E (1995) Effect of hemodialysis after contrast media application in adults with renal insufficiency. J Am Soc Nephrol 6:469. Ref Type: Abstract
74. Berger ED, Bader BD, Bösker J, Risler T, Erley CM (2000) Kontrastmittelinduziertes Nierenversagen lässt sich durch Hämodialyse nicht verhindern. Deutsche Medizinische Wochenschrift 126:162-166
75. Frank H, Werner D, Lorusso V, Klinghammer L, Daniel WG, Kunzendorf U et al (2003) Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 60(3):176-182
76. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J et al (2003) The Prevention of Radiocontrast-Agent-Induced Nephropathy by Hemofiltration. N Engl J Med 349(14):1333-1340
77. Younathan CM, Kaude JV, Cook MD, Shaw GS, Peterson JC (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. AJR Am J Roentgenol 163 (4):969-971